QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-galera-therapeutics-grtx-stock-is-nosediving

Galera Therapeutics shares are trading lower by 34.8% during Monday's session. The company said its shares will be delisted...

 galera-therapeutics-received-a-notice-of-allowance-for-its-us-patent-application-17378852-titled-pentaaza-macrocyclic-ring-complexes-possessing-oral-bioavailability-to-reduce-oral-mucositis-in-head-and-neck-cancer-patients-from-chemoradiation

https://patentcenter.uspto.gov/applications/17378852/ifw/docs

 why-doma-holdings-shares-are-trading-higher-by-around-34-here-are-20-stocks-moving-premarket

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transa...

 galera-therapeutics-q4-eps-010-beats-035-estimate

Galera Therapeutics (NASDAQ:GRTX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION